Literature DB >> 16425069

[Successful therapy of a rheumatoid leg ulcer with intravenous immunoglobulins].

A Körber1, M Lehnen, J Rietkötter, S Grabbe, J Dissemond.   

Abstract

Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disease. Leg ulcers in rheumatoid arthritis may be caused by vasculitis and are an interdisciplinary therapeutic challenge. A 69 year old women with rheumatoid arthritis and many other medical problems presented with widespread vasculitis-induced therapy-resistant ulceration on her right lower leg. Since previous therapeutic efforts had a negative effect on wound healing, we administered intravenous immunoglobulins which led to complete healing of the ulcer was achieved. Both the serological and rheumatologic features of her rheumatoid arthritis also improved. Intravenous immunoglobulins represented an effective therapeutic option with fewer side effects in the therapy of vasculitis-induced leg ulceration in this patient with rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16425069     DOI: 10.1007/s00105-005-1073-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  10 in total

1.  Leg ulcers in rheumatoid arthritis.

Authors:  Y L Pun; D R Barraclough; K D Muirden
Journal:  Med J Aust       Date:  1990-11-19       Impact factor: 7.738

Review 2.  Intravenous immune globulins: an update for clinicians.

Authors:  Irina Knezevic-Maramica; Margot S Kruskall
Journal:  Transfusion       Date:  2003-10       Impact factor: 3.157

3.  [High titers of rheumatoid factor: clinical significance].

Authors:  A Naranjo Hernández; T Rodríguez González; C Rodríguez-Lozano; S Ojeda Bruno; F Francisco Hernández; F Sánchez-García; A Bilbao Cantarero
Journal:  Rev Clin Esp       Date:  1997-04       Impact factor: 1.556

4.  Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.

Authors:  R C Lawrence; C G Helmick; F C Arnett; R A Deyo; D T Felson; E H Giannini; S P Heyse; R Hirsch; M C Hochberg; G G Hunder; M H Liang; S R Pillemer; V D Steen; F Wolfe
Journal:  Arthritis Rheum       Date:  1998-05

Review 5.  Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases.

Authors:  Z Yu; V A Lennon
Journal:  N Engl J Med       Date:  1999-01-21       Impact factor: 91.245

6.  Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis.

Authors:  K-R Chen; A Toyohara; A Suzuki; S Miyakawa
Journal:  Br J Dermatol       Date:  2002-11       Impact factor: 9.302

Review 7.  The effect of antineoplastic agents on wound healing.

Authors:  M K Ferguson
Journal:  Surg Gynecol Obstet       Date:  1982-03

Review 8.  New therapies for rheumatoid arthritis.

Authors:  F Goldblatt; D A Isenberg
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

9.  High dose intravenous immunoglobulin (IVIg) in severe refractory rheumatoid arthritis: no evidence for efficacy.

Authors:  W P Maksymowych; A Aviña-Zubieta; M Luong; A S Russell
Journal:  Clin Exp Rheumatol       Date:  1996 Nov-Dec       Impact factor: 4.473

10.  Long term treatment of rheumatoid arthritis with high doses of intravenous immunoglobulins: effects on disease activity and serum cytokines.

Authors:  C Muscat; A Bertotto; R Ercolani; O Bistoni; E Agea; M Cesarotti; G Fiorucci; F Spinozzi; R Gerli
Journal:  Ann Rheum Dis       Date:  1995-05       Impact factor: 19.103

  10 in total
  1 in total

1.  Large leg ulcers due to autoimmune diseases.

Authors:  Alexander P Rozin; Dana Egozi; Yehuda Ramon; Kohava Toledano; Yolanda Braun-Moscovici; Doron Markovits; Daniel Schapira; Reuven Bergman; Yehuda Melamed; Yehuda Ullman; Alexandra Balbir-Gurman
Journal:  Med Sci Monit       Date:  2011-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.